Towards smart assistants in two-party collaboration

Ph.DDOCTOR OF PHILOSOPH

CAPIR: Collaborative Action Planning with Intention Recognition

We apply decision theoretic techniques to construct non-player characters that are able to assist a human player in collaborative games. The method is based on solving Markov decision processes, which can be difficult when the game state is described by many variables. To scale to more complex games, the method allows decomposition of a game task into subtasks, each of which can be modelled by a Markov decision process. Intention recognition is used to infer the subtask that the human is currently performing, allowing the helper to assist the human in performing the correct task. Experiments show that the method can be effective, giving near-human level performance in helping a human in a collaborative game.Comment: 6 pages, accepted for presentation at AIIDE'1

Novel products of reaction between K[PtCl3(eugenol)] and some pyridine’s derivatives

The interaction between K[PtCl3(Eug)] (M0) and either 4-carboxylpyridine (4-Cpy) or 4-methylpyridine (4-MePy) has been studied for the first time. The structures of unusual resulting complexes, namely [PtCl(Eug-1H)(4-CPy)] (M1), trans-[PtCl2(4-MePy)2] (M2), trans-[PtCl2(Eug)(4-MePy)] (M3) were determined by means of platinum analysis, IR, 1H NMR spectroscopy and single-crystal X-ray diffraction. In these complexes, the amines coordinate with Pt(II) via the N atom and eugenol (Eug) in M1, M3 coordinates with Pt(II) via ethylenic double bond of the allyl group. In M1, the deprotonated eugenol is bound up with Pt(II) not only at the C=Callyl but also at C atom of the benzene ring to generate the metallacyclic complex. M2 and M3 possess trans configuration. Keywords. Eugenol, platinum(II) complex, 4-carboxylpyridine, 4-methylpyridine

When Humans Aren't Optimal: Robots that Collaborate with Risk-Aware Humans

In order to collaborate safely and efficiently, robots need to anticipate how their human partners will behave. Some of today's robots model humans as if they were also robots, and assume users are always optimal. Other robots account for human limitations, and relax this assumption so that the human is noisily rational. Both of these models make sense when the human receives deterministic rewards: i.e., gaining either $100 or$130 with certainty. But in real world scenarios, rewards are rarely deterministic. Instead, we must make choices subject to risk and uncertainty--and in these settings, humans exhibit a cognitive bias towards suboptimal behavior. For example, when deciding between gaining $100 with certainty or$130 only 80% of the time, people tend to make the risk-averse choice--even though it leads to a lower expected gain! In this paper, we adopt a well-known Risk-Aware human model from behavioral economics called Cumulative Prospect Theory and enable robots to leverage this model during human-robot interaction (HRI). In our user studies, we offer supporting evidence that the Risk-Aware model more accurately predicts suboptimal human behavior. We find that this increased modeling accuracy results in safer and more efficient human-robot collaboration. Overall, we extend existing rational human models so that collaborative robots can anticipate and plan around suboptimal human behavior during HRI.Comment: ACM/IEEE International Conference on Human-Robot Interactio

Assessment of Antioxidant and Antibacterial Activities of Lactobacillus farciminis HN11 as a Probiotic Candidate

Background and Objective: Lactobacillus farciminis is an obligate homofermentative bacterial species in fermented foods. Although other species such as Lactobacillus plantarum, Lactobacillus acidophilus, Lactobacillus casei and Lactobacillus rhamnosus in Lactobacillus genus have been well characterized, probiotic characteristics of Lactobacillus farciminis still need to investigate. Thus, the objective of this study was to investigate probiotic characteristics and antibacterial activity of Lactobacillus farciminis HN11 isolated from Solanum macrocarpon sauces in Hue city, Vietnam. Material and Methods: Lactobacillus farciminis HN11 was cultured in Rogosa and Sharpe media and antibacterial activity of the free-cell suspension was assessed against Escherichia coli, Vibrio parahaemolyticus K5, Vibrio parahaemolyticus KS-02, Vibrio owensii KS-05, Vibrio alginolyticus KS-08, Vibrio alginolyticus A1-1 and Staphylococcus aureus using agar well diffusion method. Various probiotic characteristics of the isolate including antibacterial and antioxidant activities, autoaggregation and coaggregation were assessed. Furthermore, hemolytic and amino-acid dercarboxylase activities were assessed for biosafety assessment. The strain abilities to resist sodium chloride and bile salts were assessed as well. Results and Conclusion: Lactobacillus farciminis HN11 exhibited significant resistance to NaCl and bile salts. The strain expressed high coaggregation abilities for Escherichia coli, significant autoaggregation abilities and antibacterial activities against Vibrio spp. and Escherichia coli. Antioxidant assessment showed that Lactobacillus farciminis HN11 contained high antioxidant activities. This strain was negative for hemolytic and amino-acid dercarboxylase activities. Moreover, ampicillin and chloramphenicol inhibited growth of Lactobacillus farciminis HN11. This study assessed characteristics of Lactobacillus farciminis HN11 and showed its great potentials as a probiotic in fermented foods, enhancing antioxidant and decreasing harmful foodborne bacteria. Although, encapsulation of the strain within acid resistance materials is suggested to better protect it against high-acid contents of the stomach. Conflict of interest: The authors declare no conflict of interest

Enhanced Private Sector Engagement for Tuberculosis Diagnosis and Reporting through an Intermediary Agency in Ho Chi Minh City, Viet Nam

Under-detection and -reporting in the private sector constitute a major barrier in Viet Nam’s fight to end tuberculosis (TB). Effective private-sector engagement requires innovative approaches. We established an intermediary agency that incentivized private providers in two districts of Ho Chi Minh City to refer persons with presumptive TB and share data of unreported TB treatment from July 2017 to March 2019. We subsidized chest x-ray screening and Xpert MTB/RIF testing, and supported test logistics, recording, and reporting. Among 393 participating private providers, 32.1% (126/393) referred at least one symptomatic person, and 3.6% (14/393) reported TB patients treated in their practice. In total, the study identified 1203 people with TB through private provider engagement. Of these, 7.6% (91/1203) were referred for treatment in government facilities. The referrals led to a post-intervention increase of +8.5% in All Forms TB notifications in the intervention districts. The remaining 92.4% (1112/1203) of identified people with TB elected private-sector treatment and were not notified to the NTP. Had this private TB treatment been included in official notifications, the increase in All Forms TB notifications would have been +68.3%. Our evaluation showed that an intermediary agency model can potentially engage private providers in Viet Nam to notify many people with TB who are not being captured by the current system. This could have a substantial impact on transparency into disease burden and contribute significantly to the progress towards ending TB

Pharmacists’ Perspectives on the Use of Telepharmacy in Response to COVID-19 Pandemic in Ho Chi Minh City, Vietnam

Introduction: Telepharmacy, the application of information and communication technologies in healthcare services, has been adopted in many countries to provide patients with pharmaceutical care. However, it has yet to be widely used in Vietnam. This study was conducted to assess the current status of use and the factors associated with the willingness to use telepharmacy of pharmacists in Vietnam. Methods: A descriptive cross-sectional study was conducted from February to July 2021; 414 pharmacists were recruited to fill in an online survey. Results: Overall, 86.7% of participants have used telepharmacy application and 87.2% of them were willing to apply telepharmacy in pharmacy practice. According to our multivariate analysis, the level of readiness was associated with positive attitude (odds ratio [OR] = 4.67; 95% confidence interval [CI]: 2.26-9.66), and a good behavior (OR = 11.34; 95% CI: 3.84-33.45). Discussion: Developing a telepharmacy system with appropriate features is essential to meet the requirements of pharmacy practice amid the spread of the COVID-19 pandemic